查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030年美國醫療器械外包市場規模,份額,趨勢分析,按服務（質量保證、合同製造）,應用（心臟病學、影像學、IVD）,類別,趨勢
市場調查報告書
商品編碼
1233182

2023-2030年美國醫療器械外包市場規模,份額,趨勢分析,按服務（質量保證、合同製造）,應用（心臟病學、影像學、IVD）,類別,趨勢

U.S. Medical Device Outsourcing Market Size, Share & Trends Analysis Report By Services (Quality Assurance, Contract Manufacturing), By Application (Cardiology, Diagnostic Imaging, IVD), By Class, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 240 Pages | 商品交期: 2-10個工作天內

價格

美國醫療器械外包市場的增長和趨勢

根據Grand View Research, Inc.的最新報告，美國醫療器械外包市場規模預計到2030年將達到585億美元，期間以11.5%的複合年增長率擴大預測期。

由於離岸趨勢的增加、對高科技醫療設備的需求不斷增加以及美國對醫療設備的嚴格監管，該市場正在增長。

醫療器械行業始終競爭激烈，冠狀動脈支架、骨科器械和傷口護理等類別日趨成熟。 由於在這些類別中進行有影響力的科學創新既困難又耗時，中小企業正在通過提供更低的價格和採用創新的商業模式來獲得市場份額。 醫療設備製造商可能會選擇外包業務模式來降低成本、管理業務風險和改善服務。 預計這些因素將在預測期內推動市場增長。

政府當局正在增加對基本設備研發的資助，從而推動市場發展。 根據 ClinicalTrials.gov，在全球範圍內，大多數設備臨床研究僅在美國進行。 在醫療器械方面，美國也正在進行大量研究。

例如，截至 2023 年 2 月，在 ClinicalTrials.gov 註冊的醫療器械研究超過 25,033 項。 醫療設備製造商正在研究美國，因為它有熟練的勞動力、先進的基礎設施和大量提供優質服務的 CRO。 所有這些因素都有望支撐大流行後的市場。

美國醫療器械外包市場報告重點。

  • 質量保證服務預計在預測期內的複合年增長率最快，達到 13.7%。 它是維持有效質量控制系統的必要組成部分，也是任何醫療器械製造的組成部分。
  • 根據應用情況，心臟病學部分在 2022 年將佔最大份額 21.8%，因為該國日益嚴重的疾病負擔推動了對心臟病學設備的需求。
  • 按類別劃分，II 類行業預計在預測期內以 11.8% 的複合年增長率增長最快。 這是由於開發這些儀器的高度複雜性以及對開發和製造這些儀器的專家團隊的需求不斷增加。

內容

第 1 章調查方法及範圍

  • 市場細分和範圍
    • 服務
    • 應用
    • 類
  • 調查方法
  • 資訊採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
    • 初步調查的內容
  • 資訊或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
    • 商品流分析（模型 1）
  • 二級資訊列表
  • 主要資訊列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望

第 3 章美國醫療器械外包市場：變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 輔助市場展望
  • 用戶視角分析
    • 消費者行為分析
    • 市場影響者分析
  • 監管框架
  • 市場變量分析
    • 市場促進因素分析
      • 監管環境的變化
      • 越來越多地將醫療設備製造業務外包給新興經濟體
      • 對先進產品的需求不斷增長
      • 合同製造商對國際標準的實施
      • 價格競爭加劇和降低成本的需求
      • 產品設計和工程的複雜性增加
    • 市場抑制因素分析
      • 外包期間的合規問題
      • 新興經濟體情景的變化
      • 法規和法律合規性
      • 合同義務
    • 行業問題
      • 關係管理
  • 美國醫療器械外包市場：分析工具
    • 波特的五力分析
    • PESTEL 分析
  • COVID-19 的影響和改革戰略

第 4 章美國醫療器械外包市場：服務細分分析

  • 定義和範圍
  • 美國醫療器械外包市場：2022 年和 2030 年市場份額分析
  • 質量保證
  • 監管諮詢服務
    • 臨床試驗申請和產品註冊
    • 監管寫作和出版
    • 法定代表人
    • 其他
  • 產品設計和開發
    • 設計與工程
    • 處理中
    • 成型
    • 包裝
  • 產品測試和滅菌
  • 產品實施
  • 產品升級
  • 產品維護
  • 合同製造
    • 配件製造
    • 組裝製造
    • 組件製造
    • 設備製造

第 5 章美國醫療器械外包市場：應用領域分析

  • 定義和範圍
  • 美國醫療器械外包市場：2022 年和 2030 年市場份額分析
  • 心臟病學
    • 一級
    • 二級
    • 三級
  • 影像診斷
    • 一級
    • 二級
    • 三級
  • 骨科
    • 一級
    • 二級
    • 三級
  • 體外診斷
    • 一級
    • 二級
    • 三級
  • 眼科
    • 一級
    • 二級
    • 三級
  • 普通外科和整形外科
    • 一級
    • 二級
    • 三級
  • 給藥
    • 一級
    • 二級
    • 三級
  • 牙科
    • 一級
    • 二級
    • 三級
  • 內窺鏡檢查
    • 一級
    • 二級
    • 三級
  • 糖尿病護理
    • 一級
    • 二級
    • 三級
  • 其他
    • 一級
    • 二級
    • 三級

第 6 章美國醫療器械外包市場：一類分析

  • 定義和範圍
  • 美國醫療器械外包市場：2022 年和 2030 年市場份額分析
  • 一級
  • 二級
  • 三級

第 7 章公司簡介

  • SGS SA
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Laboratory Corporation of America Holdings
    • 公司簡介
    • 服務基準
    • 戰略舉措
  • Eurofins Scientific
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Pace Analytical Services, Inc.
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Intertek Group plc
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Wuxi Apptec
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • North American Science Associates, LLC
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Integer Holdings Corporation
    • 公司簡介
    • 財務業績
    • 服務基準
  • ICON plc
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Sterigenics US, LLC（GTCR, LLC）
    • 公司簡介
    • 服務基準
    • 戰略舉措
  • Charles River Laboratories
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Ava□□il Medsystems, Inc.；
    • 公司簡介
    • 財務業績
    • 服務基準
  • Active Implants.
    • 公司簡介
    • 服務基準
  • Omnica Corp.
    • 公司簡介
    • 財務業績
    • 服務基準
  • Teleflex Incorporated;
    • 公司簡介
    • 服務基準
    • 戰略舉措
  • Cantel Medical Corp. (STERIS plc)
    • 公司簡介
    • 財務業績
    • 服務基準
  • Parexel International Corporation
    • 公司簡介
    • 財務業績
    • 服務基準
    • 戰略舉措
  • Medpace
    • 公司簡介
    • 財務業績
    • 服務基準
  • Premier Research
    • 公司簡介
    • 財務業績
    • 產品基準
  • IQVIA Inc.
    • 公司簡介
    • 財務業績
    • 服務基準
Product Code: 978-1-68038-600-4

U.S. Medical Device Outsourcing Market Growth & Trends:

The U.S. medical device outsourcing market size is expected to reach USD 58.5 billion by 2030, expanding at a CAGR of 11.5% during the forecast period, according to a new report by Grand View Research, Inc. This market is growing as a result of increased offshore trends, a rise in demand for high-tech medical devices, and stringent regulation for medical devices in the U.S.

The medical device industry has always been highly competitive, and categories such as coronary stents, orthopedic devices, and wound care are moving toward maturity. As high-impact scientific innovation in the above categories is difficult to achieve and is a time-consuming process, smaller companies are gaining market share by offering low prices and introducing innovative business models. Due to the convergence of mounting challenges and changing market dynamics, medical device manufacturers are likely to opt for outsourcing business models to reduce costs, manage business risks, and improve service delivery. This factor is expected to propel market growth over the forecast period.

The government authorities have escalated funds for the research and development of essential devices, thus driving the market. The majority of clinical research globally devices are conducted in the U.S. alone according to Clinical Trials .gov. In case of the medical device also significant studies are conducted in the U.S.

For instance, as of February 2023, over 25033, research for medical devices was registered in the Clinical Trials .gov. Medical device companies are conducting research in the country owing to the availability of skilled labor and advanced infrastructure, as well as the presence of a significant number of CROs offering quality services. All these factors are expected to support the market in the post-Pandemic period.

U.S. Medical Device Outsourcing Market Report Highlights:

  • The quality assurance services are projected to exhibit the fastest CAGR of 13.7% over the forecast period. This is due to the necessity of maintaining an effective quality management system, which has become an integral part of the production of every medical device
  • Cardiology segment has held the largest share of 21.8% in 2022, based on application owing to the growing demand for cardiac devices due to the rising disease burden in the country
  • Based on class, the Class II segment is expected to grow at the fastest CAGR of 11.8% over the forecast period, owing to the high complexity in developing these devices that are promoting the demand for an expert team to conduct development and manufacturing of these devices

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.2 Service
    • 1.1.3 Application
    • 1.1.4 Class
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1: Understanding the market dynamics
    • 1.10.2 Objective - 2: Understanding the market estimates and forecasts
    • 1.10.3 Objective - 3: Understanding the attributes such as strategy framework
    • 1.10.4 Objective - 4: Understanding the key service and application scopes to conclude on the market size

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 U.S. Medical device Outsourcing Market: Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 User Perspective Analysis
    • 3.2.1 Consumer Behavior Analysis
    • 3.2.2 Market Influencer Analysis
  • 3.3 Regulatory Framework
  • 3.4 Market Variable Analysis
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Changing Regulatory Landscape
      • 3.4.1.2 Increase in Off-Shoring Medical Device Manufacturing to the Emerging Economies
      • 3.4.1.3 Rising Demand for the Advanced Products
      • 3.4.1.4 Implementation of the International Standards by the Contract Manufacturers
      • 3.4.1.5 Rising Price Competition and the Requirement to Reduce Cost
      • 3.4.1.6 Increasing Complexity Concerning Product Design and Engineering
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 Compliance Issues While Outsourcing
      • 3.4.2.2 Changing Scenarios Within Developing Countries
      • 3.4.2.3 Regulatory and Legal Compliance
      • 3.4.2.4 Contractual Obligation
    • 3.4.3 Industry Challenges
      • 3.4.3.1 Managing Relationships
  • 3.5 U.S. Medical device outsourcing market: Analysis Tools
    • 3.5.1 Porter's Five Forces Analysis
    • 3.5.2 Pestel Analysis
  • 3.6. COVID-19 Impact and Reformation Strategies

Chapter 4 U.S. Medical Device Outsourcing Market: Services Segment Analysis

  • 4.1 Definition & Scope
  • 4.2 U.S. medical device outsourcing market: Market Share Analysis, 2022 & 2030
  • 4.3 Quality Assurance
    • 4.3.1 Quality Assurance Services Market, 2018 - 2030 (USD Million)
  • 4.4 Regulatory Consulting Services
    • 4.4.1 Regulatory Consulting Services Market, 2018 - 2030 (USD Million)
    • 4.4.2 Clinical Trial Application and Product Registration
      • 4.4.2.1 Clinical Trial Application and Product Registration Market, 2018 - 2030 (USD Million)
    • 4.4.3 Regulatory Writing and Publishing
      • 4.4.3.1 Regulatory Writing and Publishing Market, 2018 - 2030 (USD Million)
    • 4.4.4 Legal Representation
      • 4.4.4.1 Legal Representation Market, 2018 - 2030 (USD Million)
    • 4.4.5 Others
      • 4.4.5.1 Others Market, 2018 - 2030 (USD Million)
  • 4.5 Product Design and Development
    • 4.5.1 Product Design and Development Services Market, 2018 - 2030 (USD Million)
    • 4.5.2 Designing and Engineering
      • 4.5.2.1 Designing and Engineering Market, 2018 - 2030 (USD Million)
    • 4.5.3 Machining
      • 4.5.3.1 Machining Market, 2018 - 2030 (Usd Million)
    • 4.5.4 Molding
      • 4.5.4.1 Molding Market, 2018 - 2030 (Usd Million)
    • 4.5.5 Packaging
      • 4.5.5.1 Packaging Market, 2018 - 2030 (USD Million)
  • 4.6 Product Testing and Sterilization
    • 4.6.1 Product Testing and Sterilization Market, 2018 - 2030 (USD Million)
  • 4.7 Product Implementation
    • 4.7.1 Product Implementation Market, 2018 - 2030 (USD Million)
  • 4.8 Product Upgrade
    • 4.8.1 Product Upgrade Market, 2018 - 2030 (USD Million)
  • 4.9 Product Maintenance
    • 4.9.1 Product Maintenance Market, 2018 - 2030 (USD Million)
  • 4.10 Contract Manufacturing
    • 4.10.1 Contract Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.10.2 Accessories Manufacturing
      • 4.10.2.1 Accessories Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.10.3 Assembly Manufacturing
      • 4.10.3.1 Assembly Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.10.4 Component Manufacturing
      • 4.10.4.1 Component Manufacturing Market, 2018 - 2030 (USD Million)
    • 4.10.5 Device Manufacturing
      • 4.10.5.1 Device Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 5 U.S. Medical device outsourcing market: Application Segment Analysis

  • 5.1 Definition & Scope
  • 5.2 U.S. medical device outsourcing market: Market Share Analysis, 2022 & 2030
  • 5.3 Cardiology
    • 5.3.1 Cardiology market, 2018 - 2030 (USD Million)
    • 5.3.2 Class I
      • 5.3.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.3.3 Class II
      • 5.3.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.3.4 Class III
      • 5.3.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.4 Diagnostic Imaging
    • 5.4.1 Diagnostic imaging market, 2018 - 2030 (USD Million)
    • 5.4.2 Class I
      • 5.4.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.4.3 Class II
      • 5.4.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.4.4 Class III
      • 5.4.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.5 Orthopedic
    • 5.5.1 Orthopedic market, 2018 - 2030 (USD Million)
    • 5.5.2 Class I
      • 5.5.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.5.3 Class II
      • 5.5.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.5.4 Class III
      • 5.5.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.6 IVD
    • 5.6.1 IVD market, 2018 - 2030 (USD Million)
    • 5.6.2 Class I
      • 5.6.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.6.3 Class II
      • 5.6.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.6.4 Class III
      • 5.6.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.7 Ophthalmic
    • 5.7.1 Ophthalmic market, 2018 - 2030 (USD Million)
    • 5.7.2 Class I
      • 5.7.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.7.3 Class II
      • 5.7.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.7.4 Class III
      • 5.7.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.8 General & plastic surgery
    • 5.8.1 General & plastic surgery market, 2018 - 2030 (USD Million)
    • 5.8.2 Class I
      • 5.8.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.8.3 Class II
      • 5.8.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.8.4 Class III
      • 5.8.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.9 Drug delivery
    • 5.9.1 Drug delivery market, 2018 - 2030 (USD Million)
    • 5.9.2 Class I
      • 5.9.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.9.3 Class II
      • 5.9.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.9.4 Class III
      • 5.9.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.10 Dental
    • 5.10.1 Dental market, 2018 - 2030 (USD Million)
    • 5.10.2 Class I
      • 5.10.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.10.3 Class II
      • 5.10.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.10.4 Class III
      • 5.10.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.11 Endoscopy
    • 5.11.1 Endoscopy market, 2018 - 2030 (USD Million)
    • 5.11.2 Class I
      • 5.11.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.11.3 Class II
      • 5.11.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.11.4 Class III
      • 5.11.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.12 Diabetes care
    • 5.12.1 Diabetes care market, 2018 - 2030 (USD Million)
    • 5.12.2 Class I
      • 5.12.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.12.3 Class II
      • 5.12.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.12.4 Class III
      • 5.12.4.1 Class III market, 2018 - 2030 (USD Million)
  • 5.13 Others
    • 5.13.1 Others market, 2018 - 2030 (USD Million)
    • 5.13.2 Class I
      • 5.13.2.1 Class I market, 2018 - 2030 (USD Million)
    • 5.13.3 Class II
      • 5.13.3.1 Class II market, 2018 - 2030 (USD Million)
    • 5.13.4 Class III
      • 5.13.4.1 Class III market, 2018 - 2030 (USD Million)

Chapter 6 U.S. Medical device outsourcing market: Class Analysis

  • 6.1 Definition & Scope
  • 6.2 U.S. medical device outsourcing market: Market Share Analysis, 2022 & 2030
  • 6.3 Class I
    • 6.3.1 Class I market, 2018 - 2030 (USD Million)
  • 6.4 Class II
    • 6.4.1 Class II market, 2018 - 2030 (USD Million)
  • 6.5 Class III
    • 6.5.1 Class III market, 2018 - 2030 (USD Million)

Chapter 7 Company Profiles

    • 7.1.1 SGS SA
      • 7.1.1.1 Company Overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Service Benchmarking
      • 7.1.1.4 Strategic Initiatives
    • 7.1.2 Laboratory Corporation of America Holdings
      • 7.1.2.1 Company Overview
      • 7.1.2.2 Service Benchmarking
      • 7.1.2.3 Strategic Initiatives
    • 7.1.3 Eurofins Scientific
      • 7.1.3.1 Company Overview
      • 7.1.3.2 Financial Performance
      • 7.1.3.3 Service Benchmarking
      • 7.1.3.4 Strategic Initiatives
    • 7.1.4 Pace Analytical Services, Inc.
      • 7.1.4.1 Company Overview
      • 7.1.4.2 Financial Performance
      • 7.1.4.3 Service Benchmarking
      • 7.1.4.4 Strategic Initiatives
    • 7.1.5 Intertek Group plc
      • 7.1.5.1 Company Overview
      • 7.1.5.2 Financial Performance
      • 7.1.5.3 Service Benchmarking
      • 7.1.5.4 Strategic Initiatives
    • 7.1.6 Wuxi Apptec
      • 7.1.6.1 Company Overview
      • 7.1.6.2 Financial Performance
      • 7.1.6.3 Service Benchmarking
      • 7.1.6.4 Strategic Initiatives
    • 7.1.7 North American Science Associates, LLC
      • 7.1.7.1 Company Overview
      • 7.1.7.2 Financial Performance
      • 7.1.7.3 Service Benchmarking
      • 7.1.7.4 Strategic Initiatives
    • 7.1.8 Integer Holdings Corporation
      • 7.1.8.1 Company Overview
      • 7.1.8.2 Financial Performance
      • 7.1.8.3 Service Benchmarking
    • 7.1.9 ICON plc
      • 7.1.9.1 Company Overview
      • 7.1.9.2 Financial Performance
      • 7.1.9.3 Service Benchmarking
      • 7.1.9.4 Strategic Initiatives
    • 7.1.10 Sterigenics U.S., LLC (GTCR, LLC)
      • 7.1.10.1 Company Overview
      • 7.1.10.2 Service Benchmarking
      • 7.1.10.3 Strategic Initiatives
    • 7.1.11 Charles River Laboratories
      • 7.1.11.1 Company Overview
      • 7.1.11.2 Financial Performance
      • 7.1.11.3 Service Benchmarking
      • 7.1.11.4 Strategic Initiatives
    • 7.1.12 Avail Medsystems, Inc. ;
      • 7.1.12.1 Company Overview
      • 7.1.12.2 Financial Performance
      • 7.1.12.3 Service Benchmarking
    • 7.1.13 Active Implants.
      • 7.1.13.1 Company Overview
      • 7.1.13.2 Service Benchmarking
    • 7.1.14 Omnica Corp.
      • 7.1.14.1 Company Overview
      • 7.1.14.2 Financial Performance
      • 7.1.14.3 Service Benchmarking
    • 7.1.15 Teleflex Incorporated;
      • 7.1.15.1 Company Overview
      • 7.1.15.2 Service Benchmarking
      • 7.1.15.3 Strategic Initiatives
    • 7.1.16 Cantel Medical Corp. (STERIS plc)
      • 7.1.16.1 Company Overview
      • 7.1.16.2 Financial Performance
      • 7.1.16.3 Service Benchmarking
    • 7.1.17 Parexel International Corporation
      • 7.1.17.1 Company Overview
      • 7.1.17.2 Financial Performance
      • 7.1.17.3 Service Benchmarking
      • 7.1.17.4 Strategic Initiatives
    • 7.1.18 Medpace
      • 7.1.18.1 Company Overview
      • 7.1.18.2 Financial Performance
      • 7.1.18.3 Service Benchmarking
    • 7.1.19 Premier Research
      • 7.1.19.1 Company Overview
      • 7.1.19.2 Financial Performance
      • 7.1.19.3 Product Benchmarking
    • 7.1.20 IQVIA Inc.
      • 7.1.20.1 Company Overview
      • 7.1.20.2 Financial Performance
      • 7.1.20.3 Service Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in the U.S.
  • Fig. 5 Market research approaches
  • Fig. 6 Value - chain - based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Commodity Flow Analysis
  • Fig. 10 Volume Price Analysis
  • Fig. 11 U.S. medical device outsourcing market snapshot (2022)
  • Fig. 12 U.S. medical device outsourcing market segmentation
  • Fig. 13 U.S. medical device outsourcing market: Strategy framework
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Market driver relevance analysis (Current & future impact)
  • Fig. 17 Current shared services and outsourcing usage levels
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PEST Analysis
  • Fig. 21 U.S. medical device outsourcing market service outlook: Segment Dashboard
  • Fig. 22 U.S. medical device outsourcing market: Service movement analysis
  • Fig. 23 Quality assurance services market, 2018 - 2030 (USD Million)
  • Fig. 24 Regulatory Consulting Services market, 2018 - 2030 (USD Million)
  • Fig. 25 Clinical trial application and product registration market, 2018 - 2030 (USD Million)
  • Fig. 26 Regulatory writing and publishing market, 2018 - 2030 (USD Million)
  • Fig. 27 Legal representation market, 2018 - 2030 (USD Million)
  • Fig. 28 Others market, 2018 - 2030 (USD Million)
  • Fig. 29 Product design and development services market, 2018 - 2030 (USD Million)
  • Fig. 30 Designing and engineering market, 2018 - 2030 (USD Million)
  • Fig. 31 Machining market, 2018 - 2030 (USD Million)
  • Fig. 32 Molding market, 2018 - 2030 (USD Million)
  • Fig. 33 Packaging market, 2018 - 2030 (USD Million)
  • Fig. 34 Product testing and sterilization market, 2018 - 2030 (USD Million)
  • Fig. 35 Product implementation market, 2018 - 2030 (USD Million)
  • Fig. 36 Product upgrade market, 2018 - 2030 (USD Million)
  • Fig. 37 Product maintenance market, 2018 - 2030 (USD Million)
  • Fig. 38 Contract manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 39 Accessories manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 40 Component manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 41 Device manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. medical device outsourcing market application outlook: Segment Dashboard
  • Fig. 43 U.S. medical device outsourcing market: Application movement analysis
  • Fig. 44 Cardiology market, 2018 - 2030 (USD Million)
  • Fig. 45 Class I market, 2018 - 2030 (USD Million)
  • Fig. 46 Class II market, 2018 - 2030 (USD Million)
  • Fig. 47 Class III market, 2018 - 2030 (USD Million)
  • Fig. 48 Diagnostic imaging market, 2018 - 2030 (USD Million)
  • Fig. 49 Class I market, 2018 - 2030 (USD Million)
  • Fig. 50 Class II market, 2018 - 2030 (USD Million)
  • Fig. 51 Class III market, 2018 - 2030 (USD Million)
  • Fig. 52 Orthopedic market, 2018 - 2030 (USD Million)
  • Fig. 53 Class I market, 2018 - 2030 (USD Million)
  • Fig. 54 Class II market, 2018 - 2030 (USD Million)
  • Fig. 55 Class III market, 2018 - 2030 (USD Million)
  • Fig. 56 IVD market, 2018 - 2030 (USD Million)
  • Fig. 57 Class I market, 2018 - 2030 (USD Million)
  • Fig. 58 Class II market, 2018 - 2030 (USD Million)
  • Fig. 59 Class III market, 2018 - 2030 (USD Million)
  • Fig. 60 Ophthalmic market, 2018 - 2030 (USD Million)
  • Fig. 61 Class I market, 2018 - 2030 (USD Million)
  • Fig. 62 Class II market, 2018 - 2030 (USD Million)
  • Fig. 63 Class III market, 2018 - 2030 (USD Million)
  • Fig. 64General & plastic surgery market, 2018 - 2030 (USD Million)
  • Fig. 65 Class I market, 2018 - 2030 (USD Million)
  • Fig. 66 Class II market, 2018 - 2030 (USD Million)
  • Fig. 67 Class III market, 2018 - 2030 (USD Million)
  • Fig. 68 Drug delivery market, 2018 - 2030 (USD Million)
  • Fig. 69 Class I market, 2018 - 2030 (USD Million)
  • Fig. 70 Class II market, 2018 - 2030 (USD Million)
  • Fig. 71 Class III market, 2018 - 2030 (USD Million)
  • Fig. 72Dental market, 2018 - 2030 (USD Million)
  • Fig. 73 Class I market, 2018 - 2030 (USD Million)
  • Fig. 74 Class II market, 2018 - 2030 (USD Million)
  • Fig. 75 Class III market, 2018 - 2030 (USD Million)
  • Fig. 76 Endoscopy market, 2018 - 2030 (USD Million)
  • Fig. 77 Class I market, 2018 - 2030 (USD Million)
  • Fig. 78 Class II market, 2018 - 2030 (USD Million)
  • Fig. 79 Class III market, 2018 - 2030 (USD Million)
  • Fig. 80 Diabetes care market, 2018 - 2030 (USD Million)
  • Fig. 81 Class I market, 2018 - 2030 (USD Million)
  • Fig. 82 Class II market, 2018 - 2030 (USD Million)
  • Fig. 83 Class III market, 2018 - 2030 (USD Million)
  • Fig. 84 Others market, 2018 - 2030 (USD Million)
  • Fig. 85 Class I market, 2018 - 2030 (USD Million)
  • Fig. 86 Class II market, 2018 - 2030 (USD Million)
  • Fig. 87 Class III market, 2018 - 2030 (USD Million)
  • Fig. 88 U.S. medical device outsourcing market class outlook: Segment Dashboard
  • Fig. 89 U.S. medical device outsourcing market: Class movement analysis
  • Fig. 90 Class I market 2018 - 2030 (USD Million)
  • Fig. 91 Class II market 2018 - 2030 (USD Million
  • Fig. 92 Class III market, 2018 - 2030 (USD Million)